联合手术治疗增生型糖尿病视网膜病变合并白内障的临床观察

目的观察玻璃体手术联合白内障超声乳化术治疗增生型糖尿病视网膜病变(PDR)合并白内障的临床疗效。方法 2006年1月～2009年1月,对我科收治的48例(54眼)PDR合并不同程度白内障患者行白内障超声乳化联合玻璃体手术,观察术后视力改善程度及并发症。结果 51眼(94.44%)视力有不同程度提高,视力下降3眼(5.56%)。联合手术本身引起的最常见并发症包括虹膜新生血管(2眼)和后发性白内障(7眼)。结论玻璃体手术联合白内障超声乳化术治疗PDR合并白内障安全、有效。

Effect of combined surgery on proliferative diabetic retinopathy concomitant with cataract

Objective To observe the clinical therapeutic effect of vitrectomy combined with phacoemulsification on proliferative diabetic retinopathy concomitant with cataract. Methods Vitrectomy canbined with phacoemulsification was performed in 48 patients （54 eyes） with proliferative diabetic retinopathy（PDR） concomitant with different degrees of cataract from Jan. 2006 to Jan. 2009. Postoperative complications and vision improvement was observed. Results Vi- sion was improved at different degrees in 51 eyes, counting 94.44% and impaired in 3 eyes, counting 5.56%. The most common postoperative complications of the combined surgery included iris neovascularization （2 eyes） and after-cataract （7 eyes）. Conclusions Vitrectomy combined with phacoemulsification was a safe and effective method for the treatment of PDR concomitant with cataract.